Drugs aim to shrink skin cancer before the scalpel
NCT ID NCT06624475
Summary
This study is testing if giving immunotherapy drugs before surgery can shrink high-risk basal cell skin cancer tumors. Researchers are comparing a two-drug combination to a single drug. The goal is to see if this approach leads to better outcomes and potentially allows some patients to avoid surgery.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BASAL CELL CARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of California, Irvine
RECRUITINGIrvine, California, 92868, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of California, San Diego Moores Cancer Center
RECRUITINGLa Jolla, California, 92093, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
University of California, San Francisco
RECRUITINGSan Francisco, California, 94158, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.